MMP2 and glioblastoma: The level of MMP2 protein decreased and the level of E-cadherin protein increased, which verified that the metastasis ability of glioblastoma cells was inhibited, which is consistent with the regulatory mechanism involved in TRAF4 in breast cancer [26] (Figure 3A).